Enveric Biosciences, Inc.
ENVB· Nasdaq
ENVBEnveric Biosciences, Inc.
Filed Nov 6, 2013 · 10-Q · 37 days after period end · 0001477932-13-005130
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$4.56K | -$4.87K | -$3.69K | -$5.61K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 6, 2013 · 37 d after period end
